Bausch Health Acquires Synergy Pharmaceuticals for US$200 M
By Michelle Liu
Pharma Deals Review: Vol 2018 Issue 12 (Table of Contents)
Published: 18 Dec-2018
DOI: 10.3833/pdr.v2018.i12.2384 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Bausch Health (formerly Valeant) has made a bid to acquire Synergy Pharmaceuticals’ business assets for US$200 M in cash...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS